• OPEN AN ACCOUNT
Indian Indices
Nifty
25,149.85 -205.40
(-0.81%)
Sensex
82,500.47 -689.81
( -0.83%)
Bank Nifty
56,754.70 -201.30
( -0.35%)
Nifty IT
37,693.25 -683.40
( -1.78%)
Global Indices
Nasdaq
44,384.39 -287.26
(-0.64%)
Dow Jones
6,279.98 -21.48
(-0.34%)
Hang Seng
39,553.98 -92.38
(-0.23%)
Nikkei 225
8,941.12 -34.54
(-0.38%)
Forex
USD-INR
85.68 -0.05
(-0.06%)
EUR-INR
100.36 -0.05
(-0.05%)
GBP-INR
116.41 -0.07
(-0.06%)
JPY-INR
0.59 0.00
(0.19%)

EQUITY - MARKET SCREENER

Industry :  
BSE Code
ISIN Demat
Book Value()
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
EPS(TTM)
Face Value()
Div & Yield %
 

aar commercial company ltd
Mercury Laboratories Ltd - Board Meeting Intimation for Approval Of Audited Financial Results For The Quarter And Financial Year Ended On 31St March 2025 And To Recommend Dividend If Any And To Consider Other Items Of Agenda
May 08,2025
Mercury Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2025 inter alia to consider and approve 1. the Audited Financial Results For The Quarter And Financial Year Ended On 31St March 2025 2. To Recommend Dividend If Any 3. an appointment of Secretarial Auditor for the Financial Year 2025-26 subject to approval of shareholders 4. An appointment of Internal Auditor for the FY 2025-26 5. an appointment of Cost Auditor for the FY 2025-26. 6. To fix the date time and venue for the 44th Annual General Meeting and approve the draft notice of the 44th Annual General Meeting of the Company. 7. any other items of Agenda if any